Search Videos and More
News
Study: Ablative Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy May Improve Overall Survival in Patients with Pancreatic Cancer
A study co-led by researchers at Miami Cancer Institute, part of Baptist Health South Florida, found that ablative stereotactic magnetic resonance (MR)-guided adaptive radiation therapy may improve local control (LC) and overall survival (OS) in patients with borderline resectable (BRPC) and locally advanced pancreas cancer (LAPC).
News
When Your Patient Needs an Oral Medicine Evaluation
Whether your patient is being treated for cancer, has an autoimmune disease or an inflammatory condition that is causing an oral problem apart from the teeth and gums, they may benefit from an evaluation and treatment by an oral medicine specialist.
News
Miami Cancer Institute Leads First-in-World Brain Metastasis Trial
Baptist Health Miami Cancer Institute is leading a groundbreaking clinical trial that is studying the use of a new medication combined with stereotactic radiosurgery to combat metastatic brain cancer.
News
Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors
Researchers from Miami Cancer Institute, part of Baptist Health South Florida, recently published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs). The publication describes the current and potential impact of tissue-agnostic therapies on the management of PBTs. As part of the publication, the researchers discuss data from clinical trials of tissue-agnostic targets for PBTs in the context of challenges in managing these tumors. They also describe additional tissue-agnostic targets that hold promise for benefiting patients with PBTs.
News
Miami Cancer Institute Precision Oncology Symposium, Second Annual
Live Symposium Friday-Saturday, April 19-20, 2024 The Ritz-Carlton, Coconut Grove, Miami, Florida
News
Advanced Prostate Cancer: Genetic Testing an Invaluable Tool
A study led by Baptist Health Miami Cancer Institute shows that patients with TP53, RB1 and PTEN mutated prostate cancer have a lower overall survival rate than patients who are biomarker negative. The results emphasize the importance of genetic testing for all advanced cancer patients, the researchers say.
News
Baptist Health Miami Cancer Institute First in U.S. to Offer New Robotic Technology for Liver Cancer
In May of 2023, Govindarajan Narayanan, M.D., became the first physician to use the Epione robot in the U.S., performing an image-guided microwave ablation on a patient with a liver tumor.
News
Miami Cancer Institute to Host Fifth Global Summit on Immunotherapies for Hematologic Malignancies
Miami Cancer Institute, part of Baptist Health South Florida, announced it will host the Fifth Annual Global Summit on Immunotherapies for Hematologic Malignancies, to be held March 8-9, 2024, at the JW Marriott Hotel in Brickell, Miami, Fla.
News
Miami Cancer Institute Achieves AAHRPP Accreditation
The Association for Accreditation of Human Research Protection Programs has recognized Miami Cancer Institute for promoting ethically sound and safe human subject research practices.
News
Novel Artificial Intelligence Technology Shows Promising Results for Earlier and More Accurate Breast Cancer Detection
Data from the Centers for Disease Control and Prevention highlight that Breast Cancer is second most common form of cancer among women in the U.S. with approximately 240,000 new breast cancer diagnoses each year.
News
Miami Cancer Institute Global Summit on Immunotherapies for Hematologic Malignancies, Fifth Annual
Given the increasing frequency of hematologic malignancies, complexities of treatments with novel agents and particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields.
News
Meet the Chief: Music, Sports and Yoga Keep Surgeon Horacio Asbun, M.D., Focused
During his more than 25 years in the field, and as chief of Hepatobiliary and Pancreas Surgery at Baptist Health Miami Cancer Institute since 2018, Horacio Asbun, M.D., has been at the very forefront of global pancreatic cancer research and treatment.